Skip to main content

Table 2 Comparison of T-SPECT results in breast cancer patients that either received (Yes) or not (No) cardiotoxic adjuvant chemotherapy.

From: Myocardial perfusion imaging with 99 mTc - tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study

MPI

Left Breast

Cancer

Right Breast

Cancer

All Breast

Cancer

 

Yes

No

p

Yes

No

p

Yes

No

p

SSS

2.9 ± 3.5

4.7 ± 3.5

0.34

5.2 ± 2.4

3.1 ± 3.1

0.31

3.6 ± 3.3

4.0 ± 3.4

0.83

SRS

1.2 ± 1.9

2.0 ± 2.6

0.46

1.2 ± 1.6

0.6 ± 0.6

0.32

1.2 ± 1.7

1.4 ± 2.1

0.97

ASSS

1.8 ± 3.6

3.1 ± 3.4

0.45

3.6 ± 0.5

1.1 ± 1.3

0.32

2.4 ± 3.1

2.2 ± 2.8

0.74

S-RSS

1.7 ± 1.9

2.6 ± 2.6

0.40

4.0 ± 3.5

2.5 ± 2.7

0.60

2.4 ± 2.6

2.6 ± 2.6

0.79

  1. Cardiotoxic chemotherapy included Adriamycin in 2 patients and Epirubicin in 14 patients; MPI: myocardial perfusion imaging; SSS: summed stress score; SRS: summed rest score; ASSS: anterior wall stress score; S-RSS: the difference of SSS minus the SRS.